Laidlaw Resumes Cytori Therapeutics, Inc. (CYTX) at Buy

February 22, 2018 9:37 AM

Laidlaw resumes coverage on Cytori Therapeutics, Inc. (NASDAQ: CYTX) with a Buy rating and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found